Zhu J - Search Results

1

A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China.

Tu HY, Feng J, Shi M, Zhao J, Wang Y, Chang J, Wang J, Cheng Y, Zhu J, Tan EH, Li K, Zhang Y, Lee V, Yang CT, Su WC, Lam DC, Srinivasa BJ, Rajappa S, Ho CL, Lam KC, Hu Y, Bondarde SA, Liu X, Tian Y, Xue Z, Cseh A, Huang DC, Zhou C, Wu YL. Tu HY, et al. Among authors: zhu j. Target Oncol. 2022 Jan;17(1):1-13. doi: 10.1007/s11523-021-00859-6. Epub 2022 Jan 12. Target Oncol. 2022. PMID: 35020119 Free PMC article. Clinical Trial.

2

[Multi-factor retrospective study in 91 small cell lung cancer patients].

Liu Y, Zhu J, Liu X, Xin Y, Wang Y, Cheng Y. Liu Y, et al. Among authors: zhu j. Zhongguo Fei Ai Za Zhi. 2014 Aug 20;17(8):588-95. doi: 10.3779/j.issn.1009-3419.2014.08.02. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25130964 Free PMC article. Chinese.

3

[Association of UGT1A1 (*28, *60 and * 93) polymorphism with the adverse reactions of irinotecan chemotherapy in extensive stage small cell lung cancer].

Ma L, Chen Y, Yang C, Jiang H, Zhu J, Cheng Y. Ma L, et al. Among authors: zhu j. Zhonghua Zhong Liu Za Zhi. 2015 Jan;37(1):29-32. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 25877315 Chinese.

4

Detection of c-kit mutational status in small-cell lung cancer in a Chinese cohort.

Cheng Y, Li H, Ma L, Zhang S, Yan S, Zhu J, Wang S, Zhang R, Niu K, Liu Y. Cheng Y, et al. Among authors: zhu j. Thorac Cancer. 2014 May;5(3):225-31. doi: 10.1111/1759-7714.12082. Epub 2014 Apr 22. Thorac Cancer. 2014. PMID: 26767005 Free PMC article.

5

A study on different therapies and prognosis-related factors for 101 patients with SCLC and brain metastases.

Liu Y, Liu XH, Wang Y, Zhu J, Xin Y, Niu K, Wang S, Cheng Y. Liu Y, et al. Among authors: zhu j. Cancer Biol Ther. 2017 Sep 2;18(9):670-675. doi: 10.1080/15384047.2017.1360450. Epub 2017 Aug 16. Cancer Biol Ther. 2017. PMID: 28812423 Free PMC article.

6

Comment on: Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC.

Xu R, Zhu J. Xu R, et al. Among authors: zhu j. Lung Cancer. 2019 Jan;127:167. doi: 10.1016/j.lungcan.2018.09.018. Epub 2018 Sep 24. Lung Cancer. 2019. PMID: 30292401 No abstract available.

7

Combination strategies based on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for cancer patients: Pooled analysis and subgroup analysis of efficacy and safety.

Xu R, Shao H, Zhu J, Ju Q, Shi H. Xu R, et al. Among authors: zhu j. Medicine (Baltimore). 2019 Mar;98(13):e14135. doi: 10.1097/MD.0000000000014135. Medicine (Baltimore). 2019. PMID: 30921175 Free PMC article.

8

Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.

Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, Xin Y, Wang Y, Yang C, Cheng Y. Liu J, et al. Among authors: zhu j. J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8. J Clin Lab Anal. 2019. PMID: 31282096 Free PMC article.

9

Effect of anlotinib as a third- or further-line therapy in advanced non-small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial.

Cheng Y, Han B, Li K, Wang Q, Zhang L, Shi J, Wang Z, He J, Shi Y, Chen W, Wang X, Luo Y, Nan K, Jin F, Li B, Zhu J. Cheng Y, et al. Among authors: zhu j. Cancer Med. 2020 Apr;9(8):2621-2630. doi: 10.1002/cam4.2913. Epub 2020 Feb 16. Cancer Med. 2020. PMID: 32064794 Free PMC article. Clinical Trial.

10

Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitors.

Cheng Y, Ma L, Liu Y, Zhu J, Xin Y, Liu X, Wang Y, Zhang T, Yang C, Wang S, Cui H, Zhang L, Dai J, Shao L, Lin J, Ye J, Liu H. Cheng Y, et al. Among authors: zhu j. Lung Cancer. 2020 Jul;145:63-70. doi: 10.1016/j.lungcan.2020.04.004. Epub 2020 Apr 17. Lung Cancer. 2020. PMID: 32408134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38,996 results

Search Page